| Cancer exosomes trigger fibroblast to myofibroblast differentiation J Webber, R Steadman, MD Mason, Z Tabi, A Clayton Cancer research 70 (23), 9621-9630, 2010 | 924 | 2010 |
| Human tumor-derived exosomes down-modulate NKG2D expression A Clayton, JP Mitchell, S Linnane, MD Mason, Z Tabi The Journal of Immunology 180 (11), 7249-7258, 2008 | 629 | 2008 |
| Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2 A Clayton, JP Mitchell, J Court, MD Mason, Z Tabi Cancer research 67 (15), 7458-7466, 2007 | 605 | 2007 |
| Cancer exosomes express CD39 and CD73, which suppress T cells through adenosine production A Clayton, S Al-Taei, J Webber, MD Mason, Z Tabi The Journal of Immunology 187 (2), 676-683, 2011 | 585 | 2011 |
| Induction of heat shock proteins in B-cell exosomes A Clayton, A Turkes, H Navabi, MD Mason, Z Tabi Journal of cell science 118 (16), 3631-3638, 2005 | 552 | 2005 |
| Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes JP Webber, LK Spary, AJ Sanders, R Chowdhury, WG Jiang, R Steadman, ... Oncogene 34 (3), 290-302, 2015 | 491 | 2015 |
| Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. W Allan, Z Tabi, A Cleary, PC Doherty Journal of immunology (Baltimore, Md.: 1950) 144 (10), 3980-3986, 1990 | 419 | 1990 |
| Can urinary exosomes act as treatment response markers in prostate cancer? PJ Mitchell, J Welton, J Staffurth, J Court, MD Mason, Z Tabi, A Clayton Journal of translational medicine 7, 1-13, 2009 | 336 | 2009 |
| Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells M Moutaftsi, AM Mehl, LK Borysiewicz, Z Tabi Blood, The Journal of the American Society of Hematology 99 (8), 2913-2921, 2002 | 336 | 2002 |
| Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts R Chowdhury, JP Webber, M Gurney, MD Mason, Z Tabi, A Clayton Oncotarget 6 (2), 715, 2015 | 311 | 2015 |
| Exosomes and the MICA-NKG2D system in cancer A Clayton, Z Tabi Blood Cells, Molecules, and Diseases 34 (3), 206-213, 2005 | 192 | 2005 |
| Proteomics analysis of cancer exosomes using a novel modified aptamer-based array (SOMAscanTM) platform J Webber, TC Stone, E Katilius, BC Smith, B Gordon, MD Mason, Z Tabi, ... Molecular & Cellular Proteomics 13 (4), 1050-1064, 2014 | 169 | 2014 |
| Increased exosome production from tumour cell cultures using the Integra CELLine Culture System JP Mitchell, J Court, MD Mason, Z Tabi, A Clayton Journal of immunological methods 335 (1-2), 98-105, 2008 | 150 | 2008 |
| A clinical grade poly I: C-analogue (Ampligen®) promotes optimal DC maturation and Th1-type T cell responses of healthy donors and cancer patients in vitro H Navabi, B Jasani, A Reece, A Clayton, Z Tabi, C Donninger, M Mason, ... Vaccine 27 (1), 107-115, 2009 | 143 | 2009 |
| Human cytomegalovirus pp65-and immediate early 1 antigen-specific HLA class I-restricted cytotoxic T cell responses induced by cross-presentation of viral antigens Z Tabi, M Moutaftsi, LK Borysiewicz The Journal of Immunology 166 (9), 5695-5703, 2001 | 136 | 2001 |
| Preparation of human ovarian cancer ascites-derived exosomes for a clinical trial H Navabi, D Croston, J Hobot, A Clayton, L Zitvogel, B Jasani, ... Blood Cells, Molecules, and Diseases 35 (2), 149-152, 2005 | 133 | 2005 |
| Dominant immunosuppression of dendritic cell function by prostate-cancer-derived exosomes J Salimu, J Webber, M Gurney, S Al-Taei, A Clayton, Z Tabi Journal of extracellular vesicles 6 (1), 1368823, 2017 | 132 | 2017 |
| Apoptotic elimination of Vβ8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of Vβ8 … Z Tabi, PA McCombe, MP Pender European journal of immunology 24 (11), 2609-2617, 1994 | 129 | 1994 |
| Cancer stem cells as targets for immunotherapy AS Codd, T Kanaseki, T Torigo, Z Tabi Immunology 153 (3), 304-314, 2018 | 102 | 2018 |
| Recovery of CD8+ T-cell function during systemic chemotherapy in advanced ovarian cancer S Coleman, A Clayton, MD Mason, B Jasani, M Adams, Z Tabi Cancer Research 65 (15), 7000-7006, 2005 | 97 | 2005 |
